Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -3.80 | 5.07 |
| PEG Ratio (TTM) | -0.07 | 0.92 |
| P/S Ratio (TTM) | 0.34 | 1.38 |
| P/B Ratio (TTM) | -2.83 | 2.27 |
| P/FCF Ratio (TTM) | 4.71 | 18.28 |
| Price to 5YR AVG Earnings Ratio | -5.79 | -97.71 |
| Price to 5YR AVG FCF Ratio | 4.51 | 16.39 |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -6.92% | 1.13% |
| ROE (TTM) | 135.73% | 17.08% |
| Net Profit Margin (TTM) | -8.73% | 1.68% |
| ROIC 5YR AVG | 8.59% | 19.11% |
Growth (32%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -1,121.66% | 3.14% | -96.80% |
| Revenue | 0.68% | -0.39% | 1.54% |
| Net Income | -1,017.41% | 2.02% | -96.93% |
| Cash Flow | 159.15% | 27.36% | 19.86% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.38 | 1.21 |
| Quick Ratio (TTM) | 1.38 | 1.17 |
| D/E Ratio (TTM) | -9.09 | 0.95 |
| Interest Coverage (TTM) | 1.53 | 4.32 |
| Piotroski F-Score | 6 | 6 |
| Altman Z-Score | 0.10 | 2.16 |
| LTL to 5YR AVG FCF | 16.19 | 5.38 |
| Shares Outstanding Growth 5YR AVG | -1.85% | 2.41% |